BACKGROUND: A major discrepancy between clinical and most experimental settings of liver ischemia-reperfusion injury (IRI) is the allogenicity. METHODS: In the current study, we first established a murine model of allogeneic orthotopic liver transplantation with extended cold ischemia time (18 h). Roles of CD4 T cells in the pathogenesis of IRI in liver allografts were determined using a depleting anti-CD4 antibody. The clinical relevance of CD4 as a marker of liver IRI was analyzed retrospectively in 55 liver transplant patients. RESULTS: CD4 depletion in both donors and recipients resulted in the most effective protection of liver allografts from IRI, as measured by serum transaminase levels and liver histology. CD4 depletion inhibited IR-induced intragraft neutrophil/macrophage infiltration and proinflammatory gene expressions. Quantitative reverse-transcriptase polymerase chain reaction analysis of human liver biopsies (2 h postreperfusion) revealed that posttransplant, rather than pretransplant, CD4 transcript levels correlated positively with proinflammatory gene expression profile. When we divided patients into subgroups according to intragraft CD4 levels, the high CD4 cohort developed a more severe hepatocellular damage than that with low CD4 levels. CONCLUSIONS: CD4 T cells play a key pathogenic role in IRI of allogeneic liver transplants, and intragraft CD4 levels in the early postreperfusion phase may serve as a potential biomarker and therapeutic target to ameliorate liver IRI and improve orthotopic liver transplantation outcomes.
BACKGROUND: A major discrepancy between clinical and most experimental settings of liver ischemia-reperfusion injury (IRI) is the allogenicity. METHODS: In the current study, we first established a murine model of allogeneic orthotopic liver transplantation with extended cold ischemia time (18 h). Roles of CD4 T cells in the pathogenesis of IRI in liver allografts were determined using a depleting anti-CD4 antibody. The clinical relevance of CD4 as a marker of liver IRI was analyzed retrospectively in 55 liver transplant patients. RESULTS: CD4 depletion in both donors and recipients resulted in the most effective protection of liver allografts from IRI, as measured by serum transaminase levels and liver histology. CD4 depletion inhibited IR-induced intragraft neutrophil/macrophage infiltration and proinflammatory gene expressions. Quantitative reverse-transcriptase polymerase chain reaction analysis of human liver biopsies (2 h postreperfusion) revealed that posttransplant, rather than pretransplant, CD4 transcript levels correlated positively with proinflammatory gene expression profile. When we divided patients into subgroups according to intragraft CD4 levels, the high CD4 cohort developed a more severe hepatocellular damage than that with low CD4 levels. CONCLUSIONS: CD4 T cells play a key pathogenic role in IRI of allogeneic liver transplants, and intragraft CD4 levels in the early postreperfusion phase may serve as a potential biomarker and therapeutic target to ameliorate liver IRI and improve orthotopic liver transplantation outcomes.
Authors: Vatche G Agopian; Henrik Petrowsky; Fady M Kaldas; Ali Zarrinpar; Douglas G Farmer; Hasan Yersiz; Curtis Holt; Michael Harlander-Locke; Johnny C Hong; Abbas R Rana; Robert Venick; Sue V McDiarmid; Leonard I Goldstein; Francisco Durazo; Sammy Saab; Steven Han; Victor Xia; Jonathan R Hiatt; Ronald W Busuttil Journal: Ann Surg Date: 2013-09 Impact factor: 12.969
Authors: Yuan Zhai; Xiu-da Shen; Wayne W Hancock; Feng Gao; Bo Qiao; Charles Lassman; John A Belperio; Robert M Strieter; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: J Immunol Date: 2006-05-15 Impact factor: 5.422
Authors: Wayel Jassem; Emmanuel Xystrakis; Yasmeen G Ghnewa; Muhammed Yuksel; Oltin Pop; Marc Martinez-Llordella; Yamen Jabri; Xiaohong Huang; Juan J Lozano; Alberto Quaglia; Alberto Sanchez-Fueyo; Constantin C Coussios; Mohamed Rela; Peter Friend; Nigel Heaton; Yun Ma Journal: Hepatology Date: 2019-03-13 Impact factor: 17.425
Authors: Xiu-Da Shen; Feng Gao; Bibo Ke; Yuan Zhai; Charles R Lassman; Sei-Ichiro Tsuchihashi; Douglas G Farmer; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Liver Transpl Date: 2005-10 Impact factor: 5.799
Authors: Yuan Zhai; Xiu-Da Shen; Feng Gao; Alice Zhao; Maria Cecilia Freitas; Charles Lassman; Andrew D Luster; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Hepatology Date: 2008-01 Impact factor: 17.425